Novo Nordisk Must-Win In 2026 As It Struggles To Survive In US

Novo Nordisk shift from a market darling to a serious underperformer has set the stage for a transitional 2026 as the Danish drugmaker fights to regain investor confidence in its weight loss business. source: https://catenaa.com/industries/health/novo-nordisk-must-win-in-2026-as-it-struggles-to-survive-in-us/